ERBB2 and breast carcinoma: The first implementation of the Triplex concept combined vaccinations with HER-2-transgenic mammary carcinoma cells expressing allogeneic class I MHC molecules and systemic administrations of recombinant mouse IL-12 (Nanni et al., 2001).